姓名：耿劲松
职称：教授
个人简介：江苏连云港人，管理学博士、医学硕士。
专业研究领域：循证医疗卫生决策与管理、卫生技术评估。
论文：
1. Feng Z, Meng JY, Sun YJ, Xie TL, Lu WZ, Wang GH, Geng JS. Assessment of patients' preferences for new anticancer drugs in China: a best-worst discrete choice experiment on three common cancer types[J]. BMJ Open, 2023, 13(6):e072469
2. Geng JS, Bao HN, Feng Z, et al. Investigating patients’ preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China[J]. BMC Public Health, 2022, 22(1):1860
3. Geng JS, Chen XW, Shi JW, et al. Assessment of the satisfaction with public health insurance programs by patients with chronic diseases in China: a structural equation modeling approach[J]. BMC Public Health, 2021, 21(1):1886
4. Yu XL, Bao HN, Shi JW, Yuan XY, Qian LL, Feng Z, Geng JS. Preferences for healthcare services among hypertension patients in China: a discrete choice experiment[J]. BMJ Open, 2021, 11(12):e053270
5. Geng JS, Yu XL, Bao HN, Feng Z, Yuan XY, Zhang JY, Chen XW, Chen YL, Li CL, Yu H. Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis[J]. Front Med, 2021, 8:588013
6. Geng JS, Chen XW, Bao HN, Qian DM, Shao YT, Yu H. Patients’ preferences for health insurance coverage of new technologies for treating chronic diseases in China: a discrete choice experiment[J]. BMJ Open, 2020,10(9):e038051
7. Geng JS, Bao HN, Chen YL, Shi LL, Geng J, Wang Q, Yu H. Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis[J]. Expert Rev Anti Infect Ther, 2020,18(8):823-834
8. Geng JS, Dong JC, Li YP,Ni HJ, Jiang K, Shi LL, Wang GH. Intravenous immunoglobulins for epilepsy[J]. Cochrane Database Syst Rev, 2019, 12(12):CD008557
9. Geng JS, Yu H, Chen YY. Preparing for the introduction of hospital autonomy in Laos: an assessment of current situation and suggestions for policy-making[J]. Int J Health Plann Manage, 2016, 31(2):148-166
10. Geng JS, Yu H, Mao YY, Zhang P, Chen YY. Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes[J]. Pharmacoeconomics, 2015, 33(6):581-597
主要科研项目
主持多项省部级以上科研项目，包括国家自然科学基金项目1项、教育部人文社会科学基金2项。
讲授课程
循证医学
指导研究生情况
已毕业硕士生4名；在读硕士生2名。